On the recordOctober 29, 2019
Recent recalls issued for a class of drugs known as angiotensin II receptor blockers, or ARBs, have led to public concern about the country's sourcing of finished drug products.
Source
congress.govEditor's note · Context
Highlighting public concern over drug recalls and sourcing issues.
Share
More from Greg Walden
Sep 30, 2020
Today's hearing will examine an important topic concerning access and affordability of energy for low-income or otherwise disadvantaged households.
Nov 17, 2020
I thank our colleagues on both sides of the aisle for their work on this legislation. I urge its passage, and I yield back the balance of my time.
Nov 17, 2020
I don't believe we have any other Members wishing to speak on this legislation, so I will just close and say it is another great work product from our Energy and Commerce Committee, bipartisan legislation that I encourage our colleagues to…
Sep 29, 2020
I call on my colleagues to support this important legislation, and I yield back the balance of my time.
Other voices in this conversation
